ImmuCell Corp. (ICCC)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
7.79-0.19 (-2.38%)
At close: 4:00 PM EDT
People also watch:
HSKAHMGNCYANNYMXIMMU
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open7.97
Prev Close7.98
Bid6.00 x 2000
Ask0.00 x
Day's Range7.79 - 8.07
52wk Range5.60 - 8.29
1y Target EstN/A
Market Cap32.56M
P/E Ratio (ttm)26.14
Beta1.70
Volume1,596
Avg Vol (3m)6,621
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • ImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
    Capital Cubelast month

    ImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016

    Categories: Yahoo Finance Get free summary analysis ImmuCell Corp. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of ImmuCell Corp. – IDEXX Laboratories, Inc., Heska Corporation, Aratana Therapeutics, Inc., Merck & Co., Inc., Abaxis, Inc., VCA Inc. and Zoetis, Inc. Class A (IDXX-US, HSKA-US, PETX-US, MRK-US, ABAX-US, ... Read more (Read more...)

  • Marketwired2 months ago

    ImmuCell Announces Second Quarter 2016 Financial Results

    ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial ...

  • Marketwired2 months ago

    ImmuCell to Announce Second Quarter 2016 Financial Results

    ImmuCell Corporation , a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, will report second ...